P48L (p.Pro48Leu) variant of SOST (Sclerostin)

P48L (p.Pro48Leu) in SOST (Sclerostin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Sclerosteosis 1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data, published literature, and structural context.

P48L (p.Pro48Leu) variant details